{"id":1591,"date":"2019-10-08T20:21:37","date_gmt":"2019-10-08T19:21:37","guid":{"rendered":"http:\/\/dev5.sclerodermie.ca\/?page_id=1591"},"modified":"2019-12-20T19:09:35","modified_gmt":"2019-12-20T18:09:35","slug":"1591-2","status":"publish","type":"page","link":"http:\/\/dev5.sclerodermie.ca\/en\/blog\/1591-2\/","title":{"rendered":"Opsumit, m\u00e9dicament pour le traitement de l\u2019hypertension art\u00e9rielle pulmonaire"},"content":{"rendered":"

L\u2019hypertension art\u00e9rielle pulmonaire est une complication grave et fr\u00e9quente de la scl\u00e9rodermie qui peut rapidement conduire au d\u00e9c\u00e8s en absence d\u2019une prise en charge adapt\u00e9e.\u00a0 Opsumit (macitentan), une nouvelle option de traitement, a d\u00e9montr\u00e9 son efficacit\u00e9 sur la morbidit\u00e9 et la mortalit\u00e9 dans le traitement de l\u2019HTAP.<\/p>\n

Opsumit (macitentan) a \u00e9t\u00e9 approuv\u00e9 en novembre 2013 par Sant\u00e9 Canada pour le traitement \u00e0 long terme de l\u2019hypertension art\u00e9rielle pulmonaire,\u00a0et\u00a0\u00a0ajout\u00e9 en 2014 \u00e0 la liste de m\u00e9dicaments rembours\u00e9s par le r\u00e9gime public d\u2019assurance m\u00e9dicaments du Qu\u00e9bec (RAMQ). Cela signifie qu\u2019il est accessible aux patients atteints d\u2019HTAP couverts par la RAMQ ou un assureur priv\u00e9.<\/p>\n

Une option tr\u00e8s int\u00e9ressante pour les personnes atteintes de scl\u00e9rodermie syst\u00e9mique qui pr\u00e9sentent une HTAP. \u00a0Scl\u00e9rodermie Qu\u00e9bec est ravie et reconnaissante de la d\u00e9cision prise par le gouvernement du Qu\u00e9bec.<\/p>\n

Voici\u00a0 le lien vers l\u2019avis au ministre sur le site de l\u2019Institut national d\u2019excellence en sant\u00e9 et services sociaux (INESSS)\u00a0:\u00a0https:\/\/www.inesss.qc.ca\/activites\/evaluation-des-medicaments\/evaluation-des-medicaments\/extrait-davis-au-ministre\/opsumit-1.html<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

L\u2019hypertension art\u00e9rielle pulmonaire est une complication grave et fr\u00e9quente de la scl\u00e9rodermie qui peut rapidement conduire au d\u00e9c\u00e8s en absence d\u2019une prise en charge adapt\u00e9e.\u00a0 Opsumit (macitentan), une nouvelle option de traitement, a d\u00e9montr\u00e9 son efficacit\u00e9 sur la morbidit\u00e9 et la mortalit\u00e9 dans le traitement de l\u2019HTAP. Opsumit (macitentan) a \u00e9t\u00e9 approuv\u00e9 en novembre 2013 […]<\/p>\n","protected":false},"author":5,"featured_media":0,"parent":12,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","meta":[],"acf":[],"yoast_head":"\nOpsumit, m\u00e9dicament pour le traitement de l\u2019hypertension art\u00e9rielle pulmonaire - Sclerodermie<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/dev5.sclerodermie.ca\/en\/blog\/1591-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Opsumit, m\u00e9dicament pour le traitement de l\u2019hypertension art\u00e9rielle pulmonaire - Sclerodermie\" \/>\n<meta property=\"og:description\" content=\"L\u2019hypertension art\u00e9rielle pulmonaire est une complication grave et fr\u00e9quente de la scl\u00e9rodermie qui peut rapidement conduire au d\u00e9c\u00e8s en absence d\u2019une prise en charge adapt\u00e9e.\u00a0 Opsumit (macitentan), une nouvelle option de traitement, a d\u00e9montr\u00e9 son efficacit\u00e9 sur la morbidit\u00e9 et la mortalit\u00e9 dans le traitement de l\u2019HTAP. Opsumit (macitentan) a \u00e9t\u00e9 approuv\u00e9 en novembre 2013 […]\" \/>\n<meta property=\"og:url\" content=\"http:\/\/dev5.sclerodermie.ca\/en\/blog\/1591-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Sclerodermie\" \/>\n<meta property=\"article:modified_time\" content=\"2019-12-20T18:09:35+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/dev5.sclerodermie.ca\/en\/blog\/1591-2\/\",\"url\":\"http:\/\/dev5.sclerodermie.ca\/en\/blog\/1591-2\/\",\"name\":\"Opsumit, m\u00e9dicament pour le traitement de l\u2019hypertension art\u00e9rielle pulmonaire - Sclerodermie\",\"isPartOf\":{\"@id\":\"http:\/\/dev5.sclerodermie.ca\/#website\"},\"datePublished\":\"2019-10-08T19:21:37+00:00\",\"dateModified\":\"2019-12-20T18:09:35+00:00\",\"breadcrumb\":{\"@id\":\"http:\/\/dev5.sclerodermie.ca\/en\/blog\/1591-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/dev5.sclerodermie.ca\/en\/blog\/1591-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/dev5.sclerodermie.ca\/en\/blog\/1591-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"http:\/\/dev5.sclerodermie.ca\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Blog\",\"item\":\"http:\/\/dev5.sclerodermie.ca\/en\/blog\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Opsumit, m\u00e9dicament pour le traitement de l\u2019hypertension art\u00e9rielle pulmonaire\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/dev5.sclerodermie.ca\/#website\",\"url\":\"http:\/\/dev5.sclerodermie.ca\/\",\"name\":\"Sclerodermie\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/dev5.sclerodermie.ca\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Opsumit, m\u00e9dicament pour le traitement de l\u2019hypertension art\u00e9rielle pulmonaire - Sclerodermie","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/dev5.sclerodermie.ca\/en\/blog\/1591-2\/","og_locale":"en_US","og_type":"article","og_title":"Opsumit, m\u00e9dicament pour le traitement de l\u2019hypertension art\u00e9rielle pulmonaire - Sclerodermie","og_description":"L\u2019hypertension art\u00e9rielle pulmonaire est une complication grave et fr\u00e9quente de la scl\u00e9rodermie qui peut rapidement conduire au d\u00e9c\u00e8s en absence d\u2019une prise en charge adapt\u00e9e.\u00a0 Opsumit (macitentan), une nouvelle option de traitement, a d\u00e9montr\u00e9 son efficacit\u00e9 sur la morbidit\u00e9 et la mortalit\u00e9 dans le traitement de l\u2019HTAP. Opsumit (macitentan) a \u00e9t\u00e9 approuv\u00e9 en novembre 2013 […]","og_url":"http:\/\/dev5.sclerodermie.ca\/en\/blog\/1591-2\/","og_site_name":"Sclerodermie","article_modified_time":"2019-12-20T18:09:35+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/dev5.sclerodermie.ca\/en\/blog\/1591-2\/","url":"http:\/\/dev5.sclerodermie.ca\/en\/blog\/1591-2\/","name":"Opsumit, m\u00e9dicament pour le traitement de l\u2019hypertension art\u00e9rielle pulmonaire - Sclerodermie","isPartOf":{"@id":"http:\/\/dev5.sclerodermie.ca\/#website"},"datePublished":"2019-10-08T19:21:37+00:00","dateModified":"2019-12-20T18:09:35+00:00","breadcrumb":{"@id":"http:\/\/dev5.sclerodermie.ca\/en\/blog\/1591-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/dev5.sclerodermie.ca\/en\/blog\/1591-2\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/dev5.sclerodermie.ca\/en\/blog\/1591-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"http:\/\/dev5.sclerodermie.ca\/en\/"},{"@type":"ListItem","position":2,"name":"Blog","item":"http:\/\/dev5.sclerodermie.ca\/en\/blog\/"},{"@type":"ListItem","position":3,"name":"Opsumit, m\u00e9dicament pour le traitement de l\u2019hypertension art\u00e9rielle pulmonaire"}]},{"@type":"WebSite","@id":"http:\/\/dev5.sclerodermie.ca\/#website","url":"http:\/\/dev5.sclerodermie.ca\/","name":"Sclerodermie","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/dev5.sclerodermie.ca\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"http:\/\/dev5.sclerodermie.ca\/en\/wp-json\/wp\/v2\/pages\/1591"}],"collection":[{"href":"http:\/\/dev5.sclerodermie.ca\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/dev5.sclerodermie.ca\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/dev5.sclerodermie.ca\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"http:\/\/dev5.sclerodermie.ca\/en\/wp-json\/wp\/v2\/comments?post=1591"}],"version-history":[{"count":2,"href":"http:\/\/dev5.sclerodermie.ca\/en\/wp-json\/wp\/v2\/pages\/1591\/revisions"}],"predecessor-version":[{"id":14566,"href":"http:\/\/dev5.sclerodermie.ca\/en\/wp-json\/wp\/v2\/pages\/1591\/revisions\/14566"}],"up":[{"embeddable":true,"href":"http:\/\/dev5.sclerodermie.ca\/en\/wp-json\/wp\/v2\/pages\/12"}],"wp:attachment":[{"href":"http:\/\/dev5.sclerodermie.ca\/en\/wp-json\/wp\/v2\/media?parent=1591"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}